ZyVersa Therapeutics, Inc. (ZVSA): Total Liabilities
$12.73M
As of 2025-12-31
$14.87M
As of 2026-03-31
| Period ended | Total Liabilities | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $12.73M | +5.4% | 2026-03-31, Balance as of period end |
| 2024-12-31 | $12.08M | +9.5% | 2026-03-31, Balance as of period end |
| 2023-12-31 | $11.04M | n/a | 2025-03-27, Balance as of period end |
| No annual figure between 2021-12-31 and 2023-12-31. | |||
| 2021-12-31 | $3.65M | n/a | 2022-04-15, Balance as of period end |
Total Liabilities at similar companies
| Company | Year ended | Total Liabilities | Change YoY |
|---|---|---|---|
| ZyVersa Therapeutics, Inc. (ZVSA) | 2025-12-31 | $12.73M | +5.4% |
| Bespoke Extracts, Inc. (BSPK) | 2024-12-31 | $2.45M | +17.9% |
| Polomar Health Services, Inc. (PMHS) | 2025-12-31 | $1.61M | +19.2% |
| America Great Health (AAGH) | 2025-06-30 | $6.05M | +11.0% |
| Cell Source, Inc. (CLCS) | 2024-12-31 | $18.82M | +19.1% |
| Bio Essence Corp (BIOE) | 2025-12-31 | $2.50M | -23.2% |
| Regen BioPharma Inc (RGBP) | 2025-09-30 | $6.56M | +21.9% |
| Bioadaptives, Inc. (BDPT) | 2025-12-31 | $2.36M | +36.5% |
| Bioxytran, Inc (BIXT) | 2025-12-31 | $3.25M | +68.3% |
Compare ZVSA, BSPK, PMHS, AAGH side by side · Screen every company in Pharmaceutical Preparations ↗